ONGLYZA (SAXAGLIPTIN HYDROCHLORIDE) — FDA Approval NDA022350 (ASTRAZENECA AB)
ONGLYZA (SAXAGLIPTIN HYDROCHLORIDE) — FDA Approval NDA022350 (ASTRAZENECA AB) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ONGLYZA; Active ingredients: SAXAGLIPTIN HYDROCHLORIDE; Application number: NDA022350.
| Brand name | ONGLYZA |
|---|---|
| Active ingredients | SAXAGLIPTIN HYDROCHLORIDE |
| Application number | NDA022350 |
| Sponsor | ASTRAZENECA AB |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20090731 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →